Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 96 M87 M72 M85 M97 M84 M 338 M Research & development 172 M180 M170 M187 M164 M171 M 692 M Operating income 8.11 B8.36 B8.5 B8.54 B8.47 B8.6 B 34.11 B Non-Operating Income, Total 0298 M00—— — Interest expense, net of interest capitalized 147 M142 M142 M127 M116 M128 M 513 M Non-Operating Income, excl. Interest Expenses -147 M156 M-142 M-127 M—— — Unusual income/expense —————— — Pretax income 1.06 B1.28 B1 B943 M956 M1.02 B 3.92 B Equity in earnings 10 M37 M12 M0-3 M24 M 33 M Taxes 234 M237 M226 M143 M195 M204 M 768 M Non-controlling/minority interest 32 M34 M35 M-24 M9 M29 M 49 M After tax other income/expense —————— — Net income before discontinued operations 797 M1.01 B739 M824 M752 M786 M 3.1 B Discontinued operations —————— — Net income 797 M1.01 B739 M824 M752 M786 M 3.1 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 797 M1.01 B739 M824 M752 M786 M 3.1 B Basic earnings per share (Basic EPS) 0.580.750.50.550.50.53 2.08 Diluted earnings per share (Diluted EPS) 0.580.740.50.530.50.52 2.05 Average basic shares outstanding 1.37 B1.35 B1.47 B1.42 B1.5 B1.49 B — Diluted shares outstanding 1.38 B1.37 B1.49 B1.44 B1.51 B1.51 B — EBITDA 8.75 B8.75 B8.69 B9.27 B9.16 B9.31 B 36.43 B EBIT 8.11 B8.36 B8.5 B8.54 B8.47 B8.6 B 34.11 B Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 640 M633 M638 M732 M685 M712 M 2.77 B